Morning Buzz: Facebook (FB), Vince Holding (VNCE), KaloBios Pharmaceuticals (KBIO), Google (GOOG), (GOOGL)

wall street

Facebook, Inc. (FB) — The social media giant made headlines this morning after WhatsApp’s founder, Jan Koum, announced on Facebook that the messaging app has reached 900 million monthly active users. WhatsApp was approaching the half-billion user mark when Facebook agreed to acquire the company in February 2014 for $19 billion.

Shares of Vince Holding Corp (VNCE) tumbled more than 33% in premarket trading Friday morning, putting them on track to extend their 2015 slump of 75 percent. The nosedive is being attributed to company’s Q215 disappointing earnings report and weak guidance. In its quarterly report, the high-end clothing company said it earned $0.14 per share, well below the $0.23 per share analysts were expecting. Revenue fell 10.4% YoY to $79.99 million, below views for $86.32 million. Net income came for the second-quarter ended August 1, 2015 came in at a loss of $5 million, or ($0.14) per diluted share, compared to a profit of $10.5 million, or $0.27 per share (diluted), in the same period a year earlier.

For fiscal-year 2015, Vince Holding provided EPS guidance of $0.31 – $0.37 versus consensus of $0.84 per share. The New York-based company also issued revenue projection of $285 – $295 million, compared to the consensus revenue estimate of $342.50 million.

Vince Holding shares have plunged 64% since the beginning of the year.

KaloBios Pharmaceuticals, Inc. (KBIO) shares are up 24.75% to $3.78 in early trading. The move comes on a massive volume too with the issue currently trading more than 1.1 million shares, compared to the average daily volume of 422K shares. Not seeing any news or rumors to account for the move.

Google Inc. (GOOG), (GOOGL) – ‘The Information’ on Friday reported that after a five year absence the search giant is close to re-entering mainland China as a provider of revenue-generating consumer Web services.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.